WTC
RXRX icon

WhitTier Trust Company’s Recursion Pharmaceuticals RXRX Stock Holding History

WhitTier Trust Company’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.68K Hold
2,000
– – ﹤0.01% 1105
2026
Q1 		$6.3K Buy
2,000
+1,000
+100% +$3.86K ﹤0.01% 1120
2025
Q4 		$4.55K Hold
1,000
– – ﹤0.01% 1083
2025
Q3 		$5.49K Buy
+1,000
New +$5.25K ﹤0.01% 1065

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WhitTier Trust Company's RXRX Position: Q2 2026 in Review

WhitTier Trust Company held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 2,000 shares worth $7.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

WhitTier Trust Company first reported a position in RXRX in Q3 2025 and has held it in 4 quarters since. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • WhitTier Trust Company held 2,000 shares of Recursion Pharmaceuticals worth $7.68K as of Q2 2026.
  • WhitTier Trust Company left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1105 holding.
  • WhitTier Trust Company first reported a position in Recursion Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.